STOCKHOLM, Feb. 18, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai has notified BioArctic that the first sales milestone according to the licensing agreement has been reached. The milestone was reached as sales of Leqembi reached €200 million in Eisai...
Read More Details
Finally We wish PressBee provided you with enough information of ( Leqembi® sales reaches €200 million - first sales milestone achieved )
Also on site :